Neuroprotection mediated by changes in the endothelial actin cytoskeleton

Journal of Clinical Investigation

Volumn 106, Issue 1, 2000, Pages 15-24

  Laufs, Ulrich ^a,b   Endres, Matthias ^c   Stagliano, Nancy ^d   Amin Hanjani, Sepideh ^c   Chui, Dao Shan ^a   Yang, Shui Xiang ^a   Simoncini, Tommaso ^a   Yamada, Masaru ^c   Rabkin, Elena ^a   Allen, Philip G ^a   Huang, Paul L ^d   Böhm, Michael ^b   Schoen, Frederick J ^a   Moskowitz, Michael A ^c   Liao, James K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Stroke and Neurovascular Regulation Laboratory   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYTOCHALASIN D; TRANSFERASE;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE; VASCULAR ENDOTHELIUM;

EID: 0033917736     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9639     Document Type: Article

References (43)

1. Harrison, D.G. 1997. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100:2153-2157.
2. Huang, Z., et al. 1996. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:981-987.
3. Furchgott, R.F., and Zawadzki, J.V. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
4. Radomski, M.W., Palmer, R.M., and Moncada, S. 1990. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87:5193-5197.
5. Rudic, R.D., et al. 1998. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101:731-736.
6. Kubes, P., Suzuki, M., and Granger, D.N. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:4551-4655.
7. Huang, P.L., et al. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
8. Yamamoto, S., Golanov, E.V., Berger, S.B., and Reis, D.J. 1992. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J. Cereb. Blood Flow Metab. 12:717-726.
9. Endres, M., et al. 1998. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 95:8880-8885.
10. Morikawa, E., Huang, Z., and Moskowitz, M.A. 1992. L-arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am. J. Physiol. 263:H1632-H1635.
11. Morikawa, E., et al. 1994. L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke. 25:429-435.
12. Wang, Q., Patton, W.F., Hechtman, H.B., and Shepro, D 1997. A novel anti-inflammatory peptide inhibits endothelial cell cytoskeletal rearrangement, nitric oxide synthase translocation, and paracellular permeability increases. J. Cell Physiol. 172:171-182.
13. Levin, E.R., et al. 1998. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J. Clin. Invest. 102:1978-1985.
14. Knudsen, H.L., and Frangos, J.A. 1997. Role of cytoskeleton in shear stress-induced endothelial nitric oxide production. Am. J Physiol. 273:11347-11355.
15. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science. 279:509-514.
16. Laufs, U., and Liao, J.K. 1998. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273:24266-24271.
17. Laufs, U., LaFata, V., Plutzky, J., and Liao, J.K. 1998. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129-1135.
18. Huang, Z., et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1883-1885.
19. Van Aelst, L., and D'Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295-2322.
20. Enomoto, T. 1996. Microtubule disruption induces the formation of actin stress fibers and focal adhesions in cultured cells: possible involvement of the rho signal cascade. Cell Struct. Funct. 21:317-326.
21. Witke, W., et al. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell. 81:41-51.
22. Azuma, T., Witke, W., Stossel, T.P., Hartwig, J.H., and Kwiatkowski, D.J. 1998. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J. 17:1362-1370.
23. Laufs, U., Fata, V.L., and Liao, J K. 1997. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated downregulation of endothelial nitric oxide synthase. J. Biol. Chem. 272:31725-31729.
24. Hernandez-Perera, O., et. al. 1998. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest. 101:2711-2719.
25. Yoshizumi, M., Perrella, M.A., Burnett, J.C., Jr., and Lee, M.E. 1993. Tumor necrosis factor downregulates an endorhelial nitric oxide synchase mRNA by shortening its half-life. Circ. Res. 73:205-209.
26. Bassell, G., and Singer, R.H. 1997. mRNA and cytoskeletal filaments. Curr. Opin. Cell Biol. 9:109-115.
27. Chicurel, M.E., Singer, R.H., Meyer, C.J., and Ingber, D.E. 1998. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature 392:730-733.
28. Nasmyth, K., and Jansen, R.P. 1997. The cytoskeleton in mRNA localization and cell differentiation. Curr. Opin. Cell Biol. 9:396-400.
29. Bassell, G.J., et al. 1998. Sorting of beta-actin mRNA and protein to neurites and growth cones in culture. J. Neurosci. 18:251-265.
30. Hall, A. 1994. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol. 10:31-54.
31. Matsui, T., et al. 1996. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 15:2208-2216.
32. Matsui, T., et al. 1998. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140:647-657.
33. Ishizaki, T., et al. 1996. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 15:1885-1893.
34. Chrzanowska-Wodnicka, M., and Burridge, K. 1996. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol 133:1403-1415.
35. Amano, M., et al. 1996. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science. 271:648-650.
36. Watanabe, G., et al. 1996. Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho. Science. 271:645-648.
37. Chong, L.D., Traynor-Kaplan, A., Bokoch, G.M., and Schwartz, M.A. 1994. The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell. 79:507-513.
38. Yamada, M., et al. 2000. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J. Cereb. Blood Flow Metab, 20:709-717.
39. Mundy, G., et al. 1999. Stimulation of bone formation in vitro and in rodents by statins. Science. 286:1946-1949.
40. Laufs, U., Marra, D., Node, K., and Liao, J.K. 1999. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J. Biol. Chem. 274:21926-21931.
41. Wojciak-Stothard, B., Williams, L., and Ridley, A.J. 1999. Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering. J. Cell Biol. 145:1293-1307.
42. Essig, M., et al. 1998. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ. Res. 83:683-690.
43. Aoki, H., Izumo, S., and Sadoshima, J. 1998. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ. Res. 82:666-676.